To assess whether upregulation of TOP2A, SLC2A1, TPX2, and ASPM in NSCLC is correlated with patient overall survival (OS), we interrogated NSCLC datasets using the Kaplan Meier plotter platform (http://kmplot.com/analysis/). This evidence concerns the gene ASPM and non-small cell lung carcinoma.